Anti-Vimentin Antibody-associated Diseases
1 clinical trials · Condition
◉ Watch Anti-Vimentin Antibody-associated Diseases
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Rituximab in the Treatment of Anti-Vimentin Antibody-associated Diseases (NCT07051070) | Xuanwu Hospital, Beijing | 2025-07-01 |
Track Anti-Vimentin Antibody-associated Diseases automatically
Every clearance here is in the API, with alerts when new ones post.